Ochola-Oyier LI
Longitudinal Epidemiology and Variant Dynamics of SARS-CoV-2 in Coastal Kenya (2020-2025): Clinical Features and Wave Patterns.Lambisia AW
Nyiro J
Githinji G
Katama EN
Moraa E
Mwita JM
Mutunga M
Maina G
Bejon P
Phan MVT
Cotten M
Dellicour S
Ochola-Oyier LI
Sande C
Holmes EC
Nyagwange J
Agoti CN
Open Forum Infect Dis, (2026). 13:ofag084
Evolving patterns of antimalarial drug resistance markers in symptomatic infections in Kenya, 2013-2022.Magudha J
Ndwiga L
Akinyi MY
Wamae K
Osoti V
Kandie R
Kiplagat R
Keitany K
Bargul JL
Akala HM
Ochola-Oyier LI
Parasit Vectors, (2026). 19:
Pre-COVID-19 ex vivo cross-reactive IFN-gamma cellular response to SARS-CoV-2 spike overlapping peptides is more prevalent among Kenyan compared to Swedish adults.Wanjiku P
Orindi B
Mwacharo J
Chemweno J
Karanja HK
Kronsteiner B
Kai O
Wright D
Ochola-Oyier LI
Sundling C
Dunachie S
Warimwe GM
Farnert A
Bejon P
Ndungu FM
Nduati EW
BMC Infect Dis, (2026). 26:174
Malaria vaccine protection against intradermal or venous parasites: a randomized phase 2b human challenge trial.Kapulu MC
Orenge F
Kimani D
Kibwana E
Kibet H
Mutahi M
Datoo MS
Bellamy D
Musembi J
Ngoto O
Rashid H
Akinyi S
Mwatasa MH
Nyamako L
Keter K
Gatheru R
Mutiso A
Musyoki J
Mwacharo J
Abebe Y
James ER
Billingsley PF
Ngetsa C
Mosobo M
Makale J
Tawa B
Wamae K
Ochola-Oyier LI
Lawrie A
Ramos-Lopez F
Roberts R
Richie TL
Sim BKL
Hoffman SL
Ewer KJ
Hill AVS
Hamaluba M
Bejon P
Nat Med, (2026). 32:178-185
Characterizing Plasmodium falciparum genetic diversity and complexity of infections in clinical malaria infections in Western and Coastal Kenya using the poly-alpha microsatellite marker.Abade NA
Mgawe C
Ndwiga L
Kimenyi KM
Ochola-Oyier LI
Malar J, (2025). 24:452
Pf8: an open dataset of Plasmodium falciparum genome variation in 33,325 worldwide samples.Malaria Genomic Epidemiology Network
Abdel Hamid MM
Abdelraheem MH
Acheampong DO
Adam I
Aide P
Ajibaye O
Ali M
Almagro-Garcia J
Amambua-Ngwa A
Amenga-Etego L
Aniebo I
Aninagyei E
Ansah F
Apinjoh TO
Ariani CV
Auburn S
Awandare GA
Balmer A
Bejon P
Boene S
Bwire G
Candrinho B
Chidimatembue A
Chindavongsa K
Comiche K
Conway D
Dara A
Diakite M
Djimde A
Dondorp A
Doumbia S
Drury E
Fanello CA
Ferdig M
Figueroa K
Gamboa D
Golassa L
Goncalves S
Guindo MDA
Hamaluba M
Hanboonkunupakarn B
Howe K
Hussien M
Imwong M
Ishengoma D
Jeans J
Kabaghe A
Kamuhabwa A
Kindermans JM
Konate DS
Kwiatkowski DP
Lee C
Lee SK
Lee SJ
Ley B
Llanos-Cuentas A
Marfurt J
Matambisso G
Maude RR
Maude RJ
Mayor A
Mayxay M
Maiga-Ascofare O
McCann RS
Miles A
Miotto O
Mohamed AO
Morang'a CM
Murie K
Ngasala BE
Nguyen TN
Nolasco O
Nosten F
Noviyanti R
O'Connor I
Oboh M
Ochola-Oyier LI
Olufunke Falade C
Olukosi A
Olumide A
Olusola FI
Onyamboko MA
Oriero EC
Oyibo WA
Pannebaker D
Pearson RD
Phiri K
van der Pluijm RW
Price RN
Quang HH
Rajkumar Devaraju V
Randrianarivelojosia M
Ranford-Cartwright L
Rayner JC
Rovira-Vallbona E
Rowlands K
Ruano-Rubio V
Sanchez JF
Saute F
Shettima S
da Silva C
Simpson VJ
Suddaby S
Takken W
Thu AM
Toure M
Unlu E
Valdivia HO
van Vugt M
Waithira N
Wellems T
Wendler J
White N
Wuendrich Ogidan R
Wellcome Open Res, (2025). 10:325
A scoping review of antimalarial drug resistance markers in Kenya (1987-2022): toward a National Surveillance Framework and Data Repository.Wamae K
Magudha J
Asiimwe E
Kimani K
Kandie R
Keitany K
Snow RW
Ochola-Oyier LI
Malar J, (2025). 24:413
Serial cross-sectional school surveys identifies C469Y, P553L, R561H and A675V kelch 13 mutations associated with artemisinin resistance in Western Kenya.Osoti V
Wamae K
Musau MM
Magudha JB
Ndwiga L
Gichuki PM
Okoyo C
Rosebella K
Mahugu S
Aricha S
Kandie R
Keitany K
Kepha S
Mwandawiro C
Bejon P
Snow RW
Ochola-Oyier LI
Sci Rep, (2025). 15:38303
Assessing the Impact of SARS-CoV-2 Spike Mutations on Antibody Binding: A Comparative Assessment of the Wuhan and JN.1 Variants' Full-Length Spikes in a Multiplex Luminex Assay.Waweru G
Nyakundi R
Kutima B
Owuor S
Konyino G
Gitonga J
Lugano D
Maina A
Musyoki J
Ochola L
Omondi M
Kariuki CK
Ogongo P
Mwachari C
Shee F
Agoti C
Sande C
Uyoga S
Kagucia E
Agweyu A
Bejon P
Scott JAG
Warimwe GM
Ochola-Oyier LI
Nyagwange J
Viruses, (2025). 17:
Induction of an early IFN-gamma cellular response and high plasma levels of SDF-1alpha are inversely associated with COVID-19 severity and residence in rural areas in Kenyan patients.Wanjiku P
Orindi B
Kimotho J
Sayed S
Shah R
Saleh M
Mwacharo J
Maronga C
Olouch V
Karanu A
Shah J
Nneka Z
Ochola-Oyier LI
Abdi AI
Dunachie S
Bejon P
Nduati EW
Ndungu FM
PLoS One, (2025). 20:e0316967
Genomic and clinical epidemiology of SARS-CoV-2 in coastal Kenya: insights into variant circulation, reinfection, and multiple lineage importations during a post-pandemic wave.Lambisia AW
Katama EN
Moraa E
Mwita JM
Gallagher K
Mutunga M
Nyale E
Omungala J
Mwanga M
Murunga N
Nyiro J
Nyagwange J
Sande C
Bejon P
Githinji G
Dellicour S
Phan MVT
Cotten M
Ochola-Oyier LI
Holmes EC
Agoti CN
BMC Glob Public Health, (2025). 3:80
Emergence and transmission dynamics of the FY.4 Omicron variant in Kenya.Musundi S
Mwanga M
Lambisia A
Morobe JM
Murunga N
Moraa E
Ndwiga L
Cheruiyot R
Musyoki J
Mutunga M
Guzman-Rincon LM
Sande C
Mwangangi J
Bejon P
Ochola-Oyier LI
Nokes DJ
Agoti CN
Nyiro J
Githinji G
Virus Evol, (2025). 11:veaf035
A pragmatic randomized controlled trial of standard care versus corticosteroids plus standard care for treatment of pneumonia in adults admitted to Kenyan hospitals (SONIA).Lucinde R
Abdi A
Orindi B
Mwakio S
Gathuri H
Onyango E
Chira S
Ogero M
Isaaka L
Shangala J
Oginga IN
Wachira A
Manuthu E
Kariuki H
Nyikuli J
Wekesa C
Otedo A
Bosire H
Okoth SB
Ongalo W
Mukabi D
Lusamba W
Muthui B
Kirui N
Adembesa I
Mithi C
Sood M
Ahmed N
Gituma B
Ongaki VB
Giabe M
Omondi C
Ombajo LA
Kagucia W
English M
Hamaluba M
Ochola-Oyier LI
Kamuya D
Bejon P
Agweyu A
Akech S
Etyang AO
Wellcome Open Res, (2025). 7:269
The genome sequence of varicella-zoster virus (Varicellovirus humanalpha3) obtained by metagenomics from a patient presenting with an exanthem rash.Musundi S
Okanda D
Lambisia A
Morobe JM
Muthanje E
Ochola-Oyier LI
Carter DP
Agoti CN
Kiiru J
Githinji G
Microbiol Resour Announc, (2025). 14:e0024825
Stable Plasmodium falciparum merozoite surface protein-1 allelic diversity despite decreasing parasitaemia in children with multiple malaria infections.Yaa RM
Kimenyi KM
Palasciano HA
Obiero G
Ochola-Oyier LI
Malar J, (2025). 24:136
Identification of coxsackievirus A24 variant during an acute hemorrhagic conjunctivitis outbreak in coastal Kenya, 2024.Lambisia AW
Mwita Morobe J
Moraa E
Mwarumba S
Korir FKN
Seif Athman R
Kiptui R
Mbee M
Mugo N
Amoth P
Muange P
JHouldcroft C
Barasa E
Mwangangi J
Githinji G
CHolmes E
Ochola-Oyier LI
Agoti CN
Wellcome Open Res, (2025). 10:28
Rethinking the evidence on COVID-19 in Africa.Bejon P
Agweyu A
Ochola-Oyier LI
Hamaluba M
Kamuya D
Kinyanjui S
Barasa E
Lancet Infect Dis, (2025). 25:e463-e471
Detection of low frequency artemisinin resistance mutations, C469Y, P553L and A675V, and fixed antifolate resistance mutations in asymptomatic primary school children in Kenya.Osoti V
Wamae K
Ndwiga L
Gichuki PM
Okoyo C
Kepha S
Keitany K
Kandie R
Aricha S
Kiplagat R
Mwandawiro C
Bejon P
Snow RW
Ochola-Oyier LI
BMC Infect Dis, (2025). 25:73
Regional action needed to halt antimalarial drug resistance in Africa.Martinez-Vega R
Ishengoma DS
Gosling R
Rosenthal PJ
Dondorp A
Barnes KI
Nsanzabana C
Djimde AA
Ochola-Oyier LI
Tibenderana J
Chimumbwa J
Golassa L
Kapologwe NA
Mbacham WF
Kamya MR
Fidock DA
Komatsu R
von Seidlein L
Dhorda M
Lancet, (2025). 405:7-10
Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study.Kimotho J
Sein Y
Sayed S
Shah R
Mwai K
Saleh M
Wanjiku P
Mwacharo J
Nyagwange J
Karanja H
Kutima B
Gitonga JN
Mugo D
Karanu A
Moranga L
Oluoch V
Shah J
Mutiso J
Mburu A
Nneka Z
Betti P
Usyu Mutinda W
Abdi AI
Bejon P
Ochola-Oyier LI
Warimwe GM
Nduati EW
Ndungu FM
Wellcome Open Res, (2025). 8:350
